Rep. Sherman Introduces Bill to Regulate Prices for Every Prescription Drug in the U.S.
This bill is currently in the early stages of the legislative process and is being reviewed by three different committees in the House of Representatives. It is still active, but no future votes or hearings have been scheduled yet. There is no companion bill mentioned for this legislation.
This bill proposes a massive change to the healthcare system that would face intense opposition from the drug industry and many members of Congress.
Small business owners who provide health insurance to employees could see lower premiums as drug costs fall. However, small businesses in the pharmaceutical supply chain, including independent pharmacies, could face revenue pressures if fair prices squeeze margins across the drug distribution system.
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
No votes have been recorded for this legislation yet.
No related news coverage found for this legislation yet.
Document Type
Congressional Bill
Official Title
Regulate the Price of All Drugs Act
Analysis generated by AI. Always verify with official sources.